Management of <scp>CLL</scp> patients early in the <scp>COVID</scp>‐19 pandemic: An international survey of <scp>CLL</scp> experts
Brian Koffman(Precision Research Institute), Mazyar Shadman(University of Washington), Deborah M. Stephens(University of North Carolina at Chapel Hill), John M. Pagel(University of Washington), Lindsey E. Roeker(Memorial Sloan Kettering Cancer Center), John C. Byrd(University of Cincinnati), Matthew S. Davids(Dana-Farber Cancer Institute), Alexey V. Danilov(City of Hope), Chaitra S. Ujjani(Fred Hutch Cancer Center), Anthony R. Mato(Memorial Sloan Kettering Cancer Center), Brad Hedrick(Claremont Colleges)
Cited by 21
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k